INTRODUCTION
Infertility, the inability to conceive after at least 1 year of regular unprotected intercourse, is a common medical condition prevalent in about 15% of couples worldwide. [1] It is termed "male factor infertility" when an alteration in semen parameters or sexual/ejaculatory dysfunction is detected during evaluation. The male contributes to almost half the cases of infertility among couples [2] and in many circumstances, a cause-directed treatment strategy may be applied. However, in almost 30% of cases, [3] no definite etiology is identified, and hence, male infertility is labeled idiopathic.
In the past few years, progress in diagnostic modalities for assessment of sperm function has refined our understanding of the events leading to abnormal spermatogenesis in idiopathic male infertility. Oxidative stress (OS) has been commonly investigated and found to play a detrimental role on sperm function. Reactive oxygen species (ROS) are oxygen-containing, chemically reactive molecules that are, under normal physiologic conditions, beneficial for optimal sperm functions such as the promotion of sperm capacitation, regulation of sperm maturation, and enhancement of cellular signaling pathways. [4] Nonetheless, at higher levels, ROS have been shown to induce lipid peroxidation (LPO), sperm DNA damage, and abortive apoptosis. [5] To overcome these unwanted events, excessive ROS are naturally stabilized or deactivated by the body's antioxidant system. [6] However, when excessive amounts of ROS are produced, or when the antioxidant system fails, a state of OS develops [ Figures 1 and 2 ]. Spermatozoa are particularly vulnerable to OS as they lack the necessary cytoplasmic-antioxidant repair systems and their membrane is rich in polyunsaturated fatty acids which render them susceptible to OS-induced LPO.
25%-40% of infertile men have significantly higher levels of ROS in their semen when compared with fertile men. [7] Moreover, significant negative correlations have been detected between OS and semen parameters, fertilization rate, embryonic development, and pregnancy rate. [8, 9] Aktan et al. compared 28 men with idiopathic infertility to 14 fertile men and found significantly higher levels of OS measures in the idiopathic infertile men group. [10] Therefore, reversing the state of OS could be considered a potential step in infertility management. While antioxidant supplementation has been proposed as an approach to increase the scavenging capacity of seminal plasma, [11] controversy still surrounds its actual clinical utility. This is mainly because studies examining different antioxidant forms revealed considerable variations in the dosage or combinations used as well as outcome measures. With this review, we aim to investigate the rationale behind using different antioxidant supplements and the evidence surrounding their clinical utility.
METHODS
MEDLINE and PubMed searches were performed using the terms antioxidants and male infertility. Publications were reviewed to assess the use of antioxidants in the management of male infertility with special emphasis given to studies focusing on patients with oligoasthenoteratospermia (iOAT). The rationale behind the use of each antioxidant supplement was explained along with the dosage that is commonly used in clinical practice and the evidence about its impact on fertility outcome.
ANTIOXIDANT USE IN IDIOPATHIC MALE INFERTILITY
Antioxidants are compounds that are acquired through ingesting a balanced diet or from oral supplements. They are often prescribed for the treatment of male subfertility, principally because they are easily accessible as over the counter natural supplements. Antioxidants exist in two forms; enzymatic antioxidants (these include glutathione peroxidase (GPX)/reductase system, superoxide dismutase, and catalase) and nonenzymatic antioxidants which are principally obtained from food supplements. Among all available antioxidants, the most frequently prescribed compounds include vitamins E and C, carnitine, N-acetyl cysteine (NAC), selenium (Se), and zinc [ Table 1 ].
The empiric use of antioxidants for patients with idiopathic iOAT is aimed at improving semen parameters and thereby enhancing the probability for conception. While the plausibility of such a concept has been reported in clinical practice, scientifically acceptable evidence demonstrating benefit from antioxidant therapy in controlled human studies is scarce. Hence, antioxidant use in patients with iOAT has been largely supported by the rationale of protection that each antioxidant delivers against OS. The following antioxidants were selected based on the available evidence for their use, particularly in infertile men with iOAT.
Glutathione
GSH forms an integral part of enzyme GPX. A naturally occurring antioxidant, GPX provides the main endogenous antioxidant protection against LPO in the epididymis and testes. [33] Through scavenging lipid peroxides and hydrogen peroxide (H 2 O 2 ), these enzymes confer protection for lipid constituents, thus preserving sperm viability and motility. [34] Studies have confirmed the presence of significantly reduced DNA damage is believed to occur secondary to abortive apoptosis, alteration in sperm maturation, or to oxidative stress caused by the excessive production of reactive oxygen species by immature spermatozoa levels of GPX in infertile men as compared to fertile controls. [35] A few studies to date that have investigated the role of GSH on male infertility and have demonstrated a generally positive effect on semen parameters. [12] [13] [14] In a placebo-controlled, double-blind, cross-over trial, 600 mg of GSH administered intramuscularly every other day for 2 months led to an improvement in sperm motility and morphology in 20 men with varicocele or male germ-free genital tract inflammation. [13] In vitro studies have confirmed the protective effect of glutathione reductase on tail-beat frequency, LPO reduction, and improvement of sperm membrane characteristics. [36] GSH is poorly absorbed from the gastrointestinal tract making its preferred parenteral method of administration a major drawback to its widespread use.
Vitamin E
Vitamin E (α-tocopherol) is an organic fat soluble compound located mainly in cell membranes. It is a powerful chain-breaking antioxidant capable of quenching free hydroxyl radicals and superoxide anions thereby reducing LPO initiated by ROS at the level of plasma membranes. Therefore, this antioxidant shields sperm membrane components from OS damage. A direct relationship has been detected between the levels of Vitamin E in seminal plasma and the percentage of motile spermatozoa in semen. [37] Furthermore, lower levels of Vitamin E were observed in the semen of infertile men. [38] In contrast to earlier studies demonstrating no benefit from vitamin E supplementation in the treatment of male infertility, [39, 40] recent placebo-controlled studies have suggested a favorable outcome. Suleiman et al. investigated the oral use of 300 mg of daily vitamin E in infertile men, revealing significant improvement in sperm motility concomitant with reduction of OS measures in the treatment group. Moreover, they reported a 21% spontaneous pregnancy rate in the treatment group compared to 0% in the placebo group. [15] Studies investigating vitamin E in combination with other vitamins have specifically revealed a significant improvement in sperm concentration [16, 17] together with a decrease in sperm DNA fragmentation (SDF) [16] and seminal ROS. [17] Keskes-Ammar et al. randomized 54 infertile men into two groups; one receiving 400 mg Vitamin E + 225 µg Se while the other receiving 4-5 g Vitamin B daily for 3 months. [18] The authors reported significant reductions in malondialdehyde level, a marker for LPO, together with significant improvement of sperm motility and viability in the Vitamin E/Se group compared with the other group. [18] However, the small sample size is a limitation of this study.
Vitamin C
Vitamin C is a water-soluble compound that exists in seminal plasma at a concentration 10 times higher than in blood The level of evidence is modified from the Oxford Centre for Evidence-based Medicine (http://www.cebm.net/ oxford-centre-evidence-based-medicine-levels-evidence-march-2009/) were Grade A is based on systemic reviews of RCTs or individual RCT of good quality; Grade B is based on well-designed studies (prospective, cohort) and lower quality RCT; and Grade C is based on poorer quality studies (retrospective, case series, and expert opinion). SDF=Sperm DNA fragmentation, OS=Oxidative stress, RCT=Randomized controlled trial serum. [41] The rationale behind its use stems from its ability to neutralize hydroxyl, superoxide, and hydrogen peroxide radicals, thus providing protection against endogenous oxidative damage. [42] Lower Vitamin C levels and higher ROS levels were observed in the seminal plasma of men with asthenozoospermia. [43] Moreover, Vitamin C had a significant positive correlation, in a dose-dependent manner, with sperm motility [44] and percentage of normal sperm morphology. [45] Vitamin C was mainly investigated in combination with other vitamins and minerals. [19, 46] Of particular interest was the combination of Vitamins C and E as the hydrophilicity of the former and lipophilicity of the latter is believed to have a synergistic effect in reducing peroxidative damage on spermatozoa.
[46] Such a hypothesis was not confirmed in a randomized controlled double-blind study conducted on men with iOAT, where Rolf et al. failed to show an improvement in semen parameters, sperm survival, or pregnancy rates after the administration of high-doses of Vitamin C and E for 56 days. [40] Despite that, more recent studies have conveyed a beneficial effect for antioxidant regimens-containing Vitamin C in different clinical scenarios. The combination of Vitamin C and E significantly improved SDF, clinical pregnancy, and implantation rates in men undergoing intracytoplasmic sperm injection. [19] Similarly, Omu et al. revealed that a combination treatment with zinc, Vitamin E, and C improved sperm motility, SDF, and measures of OS in men with asthenozoospermia. [20] Additional prospective randomized clinical trials examining the influence of Vitamin C in patients with iOAT is required.
Carnitines
Carnitine is another water-soluble antioxidant involved in sperm metabolism and considered as a fuel source actively involved in sperm motility. In vitro studies have confirmed this effect where sperm cultured in media containing carnitine demonstrated higher motility and viability in comparison to controls. [47, 48] Men with OAT were found to have significantly lower levels of carnitine in their semen. [49] The main forms used in the treatment of male subfertility are L-carnitine (LC) and L-acetyl carnitine (LAC).
In vivo studies examining the effect of carnitines on semen parameters have echoed similar improvements in sperm motility though not consistently. Sigman et al. in a small sized (n = 21) prospective randomized double-blinded placebo-controlled trial of patients with iOAT failed to report a significant improvement in sperm parameters after treatment with LC and LAC. [50] Conversely, Cavallini et al. investigated patients with low-grade varicocele and idiopathic infertility and demonstrated a significant improvement in all semen parameters in addition to higher spontaneous pregnancy rates among patients treated with LC and LAC in comparison to placebo (21.8% vs. 1.7%, respectively). [21] Despite the significant improvement, the inclusion of patients with varicocele in the study population may make it difficult to correctly interpret the effect of LC and LAC in men with idiopathic infertility. Further double-blind placebo-controlled trials investigating LC and LAC in idiopathic asthenozoospermia conveyed significant improvement in sperm motility and pregnancy rate. [22, 23, 51] Coenzyme-Q10
Coenzyme-Q10 (CoQ-10) is an essential antioxidant, ubiquitous to almost all body tissues and available at high concentrations in sperm mitochondria playing an integral role in energy production. [52] Its involvement in cellular respiration and energy production justifies its use as a pro-motility and antioxidant molecule. CoQ-10 levels in seminal plasma were found to have a linear correlation with sperm count and motility. Furthermore, the in vitro addition of Co-Q10 to semen samples of men with asthenozoospermia resulted in an improvement in sperm motility. [53] Co-Q10 may also convey protection against OS due to its ability to inhibit hyperoxide formation. Alleva et al. reported a significant negative correlation between Co-Q10 levels and H 2 O 2 . [54] Several studies have assessed the impact of CoQ-10 on semen parameters in patients with iOAT. Safarinejad randomly assigned 212 infertile men with iOAT to receive 300 mg Co-Q10 orally or placebo for a period 26 weeks. He demonstrated a statistically significant increase in sperm density and motility with CoQ-10 therapy (P = 0.01). [24] In a different study, the same author further reported a beneficial effect on spontaneous pregnancy rate in men receiving CoQ-10. [25] In a meta-analysis of three randomized controlled trials on Co-Q10 use in iOAT, Lafuente et al. reported significant improvement in sperm motility and concentration in men receiving Co-Q10 without a significant increase in pregnancy rates. [26] N-Acetyl cysteine NAC is an amino acid that exhibits antioxidant properties after being converted in the body to cysteine which is a precursor of glutathione. It is also capable of directly reducing OS through scavenging free radicals. [55] In vitro studies have demonstrated a beneficial role for NAC on germ cell survival as a result of its antioxidant properties. [56] The incubation of semen samples with NAC for 20 min significantly reduced ROS levels and resulted in an improvement of sperm motility. [57] In a randomized placebo-controlled study of 120 patients with idiopathic infertility, treatment with 600 mg of NAC daily resulted in a significant improvement in sperm motility in comparison to placebo. [27] In addition, authors evaluated OS measures and reported higher serum total antioxidant capacity and lower total peroxide and OS index in the NAC-treated group compared with the placebo group. Another double-blind, placebo-controlled trial randomized 468 infertile men with iOAT into four groups; 200µg Se, 600 mg NAC, 200 µg Se + 600 mg NAC, and placebo. [28] Authors reported a significant improvements in all semen parameters in the Se and NAC groups with an additive effect in the combination group. Furthermore, a dose-dependent positive correlation was detected between the sum of Se/NAC concentrations, and mean sperm concentration (r = 0.67, P = 0.01), motility (r = 0.64, P = 0.01), and percent of normal morphology (r = 0.66, P = 0.01). [28] While the above-mentioned studies advocate the usage of NAC in men with infertility to improve semen quality, it failed to investigate the degree of improvement in pregnancy rate.
Selenium
Se is an essential trace element involved in spermatogenesis. It provides protection for sperm DNA against OS damage in a mechanism that is not very well-established. It is believed that Se augments the function of biologic glutathione since it is a major constituent of a specific group of proteins called selenoenzymes. More than 25 selenoproteins exist, such as phospholipid hydroperoxide GPX [58] and sperm capsular selenoprotein GPX, [59] which help maintain the sperm structural integrity. [60] Morphologic sperm midpiece abnormalities and impairment of sperm motility are among the most common sperm abnormalities associated with Se deficiency. [61] Se has mainly been studied in combination with other vitamins, specifically Vitamin E as it is well known to work in synergy with Se as an antiperoxidant. [62] As previously noted in the randomized controlled trial by Keskes-Ammar et al., the combination of Vitamin E and Se had protective effects on sperm motility and measures of LPO. [18] Safarinejad et al. [28] reported a statistically significant improvement in all semen parameters in men receiving 200ug of Se alone or in combination with NAC for 26 weeks. [28] In a recent literature review, Se was found to have a favorable influence on viability of spermatozoa providing protection against ROS. [63] 
Zinc
Zinc is an essential mineral involved in the metabolism of DNA and RNA. It has antiapoptotic and antioxidant properties with a potential positive effect on spermatogenesis. Zinc concentrations of seminal plasma were found to be significantly higher in fertile men in comparison to subfertile men. [64] The antioxidant properties of zinc, however, were first utilized in antiaging supplements and immune boosters. The protective effect zinc has on sperm structure may probably be the most important advocate for male fertility. Sperm flagellar abnormalities, such as hypertrophy and hyperplasia of the fibrous sheath, axonemal disruption, defects of the inner microtubular dynein arms, and abnormal or absent midpiece have all be associated with zinc deficiency. [20] Studies have shown a beneficial effect for zinc supplementation in patients with iOAT demonstrated by improvements in sperm concentration, progressive motility, sperm integrity, and pregnancy rates. [29, 65] Omu et al. randomized 45 men with asthenozoospermia into 4 groups; zinc only, zinc + Vitamin E, zinc + Vitamins E and C, and no therapy. After a period 3 months, zinc therapy alone or in combination with Vitamin E or Vitamin E + C was associated with significant improvement in sperm parameters and reduction in OS, sperm apoptosis, and SDF. [20] The results of this study are limited due to small sample size.
Folic acid
Folic acid is a B Vitamin (B9) that plays a vital role in nucleic acid synthesis and amino acid metabolism. It has free radical scavenging abilities which provoked its use as a potential antioxidant for the treatment of male subfertility. Folic acid intake has been linked with lower frequency of SDF. One study demonstrated that daily consumption of 700 µg of folic acid was associated with a 30% lower risk of disomy X and 21, sex nullisomy, and DNA aneuploidy. [66] No robust evidence exists to support the use of folic acid for the treatment of men with idiopathic infertility. Murphy et al. [67] examined the association between idiopathic infertility with variants in folic acid-related genes and measures in blood. Despite finding significant correlations between folic acid related gene (phosphatidylethanolamine N-methyltransferase M175V) and serum folic acid levels with male infertility, no significant relationship was detected with semen parameters. In a double-blind, placebo-controlled interventional study, 108 fertile men and 103 subfertile men were randomized into four groups; folic acid only, zinc only, a combination, and placebo. [30] After 26 weeks of treatment, a statistically significant increase in sperm concentration was noted among subfertile men receiving combination therapy. Another study of similar design by Ebisch et al. [68] compared daily treatment with folic acid (5 mg/day) + zinc sulfate (66 mg/day) to placebo on 47 fertile and 40 subfertile men for a period of 26 weeks and reported significant improvement in sperm concentration in the treatment group only.
Lycopene
Lycopene is a naturally synthesized carotenoid present in fruits and vegetables. It plays a major role in the human redox defense system as it has the highest quenching ability against singlet oxygen, a high-energy form of oxygen. [69] Lycopene is detected at high concentrations in human testes and seminal plasma with levels that tend to be lower in men suffering from infertility. [70] Gupta and Kumar investigated oral lycopene therapy in 30 men with iOAT, who were given 2 mg of lycopene twice daily for 3 months. [31] The authors reported statistically significant improvements in sperm concentration and motility in 66% and 53% of patients, respectively. However, the improvements were only significant in patients who had baseline sperm concentration more than 5 million/ml. Mohanty et al. treated fifty patients with iOAT with 8 mg of lycopene daily until an improvement in semen parameters was detected or pregnancy was achieved. After a follow-up period of 1-year duration, sperm concentration, motility, and morphology improved in 70%, 54%, and 38% of patients, respectively, while pregnancy was achieved in 36% of patients.
[32]
SUMMARY OF ANTIOXIDANTS USE FOR MALE INFERTILITY
While the majority of studies investigated the effect of antioxidants on semen parameters, few addressed their influence on pregnancy or live birth rate. The available systemic reviews perhaps provide a summary of the effect of antioxidant therapy for male infertility. [71] Ross et al. [72] analyzed 17 randomized trials, including a total of 1665 infertile men looking for changes in semen parameters or reported pregnancy rates. Statistically significant improvements in semen parameters were detected in 14 out of 17 trials. Pregnancy rate was reported in seven trials, six of them showed a significant improvement after antioxidant therapy. The authors concluded that the use of oral antioxidants in infertile men may have a beneficial effect on sperm quality and pregnancy rates. The impact of oral antioxidants on measures of sperm OS and DNA damage was investigated by Gharagozloo and Aitken. [73] They selected 20 trials assessing such an association and reported a significant reduction of OS or DNA damage after treatment with antioxidants in 19 out of the 20 studies selected. Moreover, an improvement in sperm motility, particularly in asthenospermic patients was significantly observed. [73] Although the published studies generally demonstrate a favorable effect of antioxidants on infertile men, the optimal type and dose of antioxidants together with their exact mechanism of action is still unknown. Based on the available grade of evidence and our clinical experience in this field, we propose the utility of combinations of Vitamins E and C, carnitines, CoQ-10, NAC together with minerals such as zinc and Se for the treatment of patients with idiopathic infertility.
CONCLUSION
Antioxidants are under active investigation in the treatment of male infertility. However, collection of high-quality evidence, such as that from double-blind placebo-controlled trials, on the efficacy of these compounds is a slow and arduous process. While a number of studies have confirmed a beneficial effect for antioxidants in reversing OS-induced sperm dysfunction specifically in patients with idiopathic male infertility, there are few controlled or randomized clinical trials, thus limiting strong evidence in support of their use. Nonetheless, an individualized treatment approach is preferred with adjustments in dose and type of antioxidant made according to the clinical presentation and/or the level of seminal OS.
